A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses

NCT07330674 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

68

Enrollment

INDIV

Sponsor class

Conditions

Age Related Macular Degeneration (ARMD)
AMD - Age-Related Macular Degeneration

Interventions

DRUG: ABF-101
DRUG: Placebo

Sponsor

Aptabio Therapeutics, Inc.